Abstract
To determine the relation between neutrophil function and the clinical characteristics of systemic lupus erythematosus (SLE), the superoxide anion (\({\text{O}}_2^ - \)) production by neutrophils, mediated by FcγR and FcγR/CR cooperation, was studied in 64 SLE patients classified according to their prevalent clinical manifestations. Three clinically distinct patterns were designated: (1) manifestations associated with the occurrence of cytotoxic antibodies (SLE-I group); (2) manifestations associated with circulating immune complexes (IC; SLE-II group), and (3) manifestations associated with IC and cytotoxic antibodies (SLE-III group). \({\text{O}}_2^ - \) production was evaluated by a lucigenin-dependent chemiluminescent assay in neutrophils stimulated with IC-IgG opsonized or not with complement. No difference in \({\text{O}}_2^ - \) production was observed when neutrophil responses from healthy controls were compared to the unclassified patients. However, when the SLE patient groups were considered, the following differences were observed: (1) SLE-I neutrophils showed lower \({\text{O}}_2^ - \) production mediated by the IgG receptor (FcγR) with the cooperation of complement receptors (FcγR/CR) than observed in the SLE-II, SLE-III, and healthy groups; (2) neutrophils from the SLE-II group showed a decreased \({\text{O}}_2^ - \) production mediated by FcγR/CR compared to the SLE-III group, (3) SLE-III neutrophils produced more \({\text{O}}_2^ - \) than neutrophils from the SLE-II and control groups, and (4) CR showed inefficiency in mediating the \({\text{O}}_2^ - \) production by neutrophils from the SLE-I group. Comparative experiments on the kinetics of chemiluminescence (CL; T max and CLmax) disclosed differences only for the SLE-I group. Taken together, these results suggest that differences in oxidative metabolism of neutrophils mediated by FcγR/CR may reflect an acquired characteristic of disease associated with distinct clinical manifestations.
Similar content being viewed by others
Abbreviations
- aCL:
-
anticardiolipin
- ACR:
-
American College of Rheumatology
- ANA:
-
antinuclear antibodies
- CLmax :
-
maximum rate of chemiluminescence
- CFD:
-
complement fixation diluent
- CR:
-
complement receptor
- DEAE:
-
diethylaminoethyl
- EDTA-:
-
ethylenediaminetetraacetate
- FcγR:
-
Fc gamma receptor
- HBSS:
-
Hanks’ balanced saline solution
- IC:
-
immune complexes
- INHS:
-
inactivated normal human serum
- LAC:
-
lupus anticoagulant
- NHS:
-
normal human serum
- \({\text{O}}_2^ - \) :
-
superoxide anion
- OVA:
-
ovalbumin
- SEM:
-
standard error of the mean
- SLE:
-
systemic lupus erythematosus
- SLEDAI:
-
systemic lupus erythematosus disease activity index
- T max :
-
time interval for the maximum rate of chemiluminescence
References
Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84
Kurien BT, Hensley K, Bachmann M et al (2006) Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 41:549–556
Alarcón-Segovia D, Alarcón-Riquelme ME (1999) Etiopathogenesis of Systemic Lupus Erythematosus: a tale of three troikas. In: Lahita RG (ed) Systemic lupus erythematosus. Academic, San Diego, CA, pp 55–65
Davies KA, Schifferli JA, Walport MJ (1994) Complement deficiency and immune complex disease. Springer Semin Immunopathol 15:397–416
Tsokos GC (1999) Overview of cellular immune functions in systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Academic, San Diego, CA, pp 17–54
Ohara M, Shirado M, Miyata M et al (1983) Natural and antibody-dependent cellular cytotoxicity of polymorphonuclear leukocytes. Tohoku J Exp Med 140:59–66
Hebert LA (1991) The clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 17:352–361
Brown EJ (1992) Complement receptors, adhesion, and phagocytosis. Infect Agents Dis 1:63–70
Colten HR, Rosen FS (1992) Complement deficiencies. Annu Rev Immunol 10:809–834
Van der Pol W, Van de Winkel JG (1998) IgG receptor polymorphisms: risk factors for disease. Immunogenetics 48:222–232
Iliopoulos AG, Tsokos GC (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 25:318–336
Hepburn AL, Mason JC, Wang S et al (2006) Both Fcg and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol 146:133–145
Szücs G, Kávai M, Kiss E et al (1995) Correlation of IgG Fc receptors on granulocytes with serum immune complex level in systemic lupus erythematosus. Scand J Immunol 42:577–580
Marzocchi-Machado CM, Alves CM, Azzolini AE et al (2002) Fcγ and complement receptors: expression, role and cooperation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 11:240–248
Enenkel B, Jung D, Frey J (1991) Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus. Eur J Immunol 21:659–663
Wilson JG, Ratnoff WD, Schur PH et al (1986) Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum 29:739–747
Boros P, Odin JA, Chen J et al (1994) Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease. J Immunol 152:302–306
Witte T, Gessner JE, Gotze O et al (1992) Complement receptor 3 deficiency in systematic lupus erythematosus. Immun Infekt 20:60–61
Lahita RG (1999) The clinical presentation of systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Academic, San Diego, CA, pp 325–336
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
Dresser DW (1986) Immunization of experimental animal. In: Weir DM (ed) Handbook of experimental immunology. Blackwell, Oxford, GB, pp 8.1–8.21
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 15:680–685
Gadd KJ, Reid KB (1981) The binding of complement component C3 to antibody antigen aggregates after activation of the alternative pathway in human serum. Biochem J 195:471–480
Lucisano YM, Mantovani B (1984) Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG. J Immunol 132:2015–2020
Cheung K, Archibald AC, Robinson MF (1983) The origin of chemiluminescence produced by neutrophils stimulated by opsonized zymosan. J Immunol 130:2324–2329
Alves CMOS, Marzocchi-Machado CM, Carvalho IF et al (2003) Application of the chemiluminescence systems to evaluate the role of Fcγ and complement receptors in stimulating the oxidative burst in neutrophils. Talanta 60:601–608
Sherer Y, Gorstein A, Fritzler M et al (2004) Autoantibody explosion in Systemic Lupus Erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501–537
Mir A, Balsalobre B (1994) Inhibition of complement-dependent phagocytosis by autoantibodies against C3b-receptor (CR1) in a case of systemic lupus erythematosus. J Intern Med 235:284–285
Schifferli JA, Peters DK (1983) Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet 2:957–959
Nydegger UE, Kazatchkine MD (1986) Modulation by complement of immune complex processing in health and disease in man. Prog Allergy 39:361–392
Mills JA (1994) Systemic lupus erythematosus. N Engl J Med 330:1871–1879
Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421–432
Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265:1095–1098
Sylvestre D, Clynes R, Ma M et al (1996) Immunoglobulin G-mediated inflammatory responses develop normally in complement deficient mice. J Exp Med 184:2385–2392
Clynes R, Dumitru C, Ravetch JV (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052–1054
Yu CL, Chang KL, Chiu CC et al (1989) Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections. Scand J Rheumatol 18:97–105
Lucisano YM, De-Mello AM, Vasques ER et al (1998) Precipitated immune complexes of IgM induce the generation of reactive oxygen species by rabbit polymorphonuclear leucocytes. Braz J Med Biol Res 31:793–797
Munoz LE, Herrmann M, Gaipl US (2005) An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity. Z Rheumatol 64:370–376
Acknowledgments
We thank the patients of HCFMRP-USP and the volunteers of the laboratory staff for their cooperation. We also thank Dr Flávio Calil Petean (HC-FMRP-USP) for his help in selecting the SLE patients according to ACR classification criteria and SLEDAI, and Teresa Cristina Lopes Guimarães for secretarial assistance. This study was supported by FAPESP fellowships 98/05462-0 and 96/09626-2.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Alves, C.M.O.S., Marzocchi-Machado, C.M., Louzada-Junior, P. et al. Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol 27, 701–708 (2008). https://doi.org/10.1007/s10067-007-0768-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0768-x